Oral contraception does not alter typical post-exercise interleukin-6 and hepcidin levels in females

Marc Sim; Brian Dawson; Grant Landers; D.W. Swinkels; H. Tjalsma; Bu Yeap; Debbie Trinder; Peter Peeling

doi:10.1016/j.jsams.2013.11.008

Oral contraception does not alter typical post-exercise interleukin-6 and hepcidin levels in females

Marc Sim, Brian Dawson, Grant Landers, D.W. Swinkels, H. Tjalsma, Bu Yeap, Debbie Trinder, Peter Peeling

Research output: Contribution to journal › Article

11 Citations (Scopus)

Abstract

© 2013 Sports Medicine Australia. Objectives: The post-exercise interleukin-6 (IL-6) and hepcidin response was investigated during the hormone-deplete and hormone-replete phases of an estradiol and progestogen regulated oral contraceptive cycle (OCC). Design: Counterbalanced, repeated measures cross-over study. Methods: Ten active female monophasic oral contraceptive pill (OCP) users completed two 40min treadmill running trials at 75% of their pre-determined peak oxygen uptake velocity (vVO2peak). These trials were randomly performed in two specific phases of the OCC: (a) Day 2-4, representing a hormone-free withdrawal period (D-0); (b) Day 12-14, representing the end of the first week of active hormone therapy (D+7). Venous blood samples were drawn pre-, post- and 3h post-exercise. Results: In both trials, serum IL-6 was significantly elevated (p

Original language	English
Pages (from-to)	8-12
Journal	Journal of Science and Medicine in Sport
Volume	18
Issue number	1
DOIs	https://doi.org/10.1016/j.jsams.2013.11.008
Publication status	Published - 2015

Access to Document

10.1016/j.jsams.2013.11.008

Fingerprint Dive into the research topics of 'Oral contraception does not alter typical post-exercise interleukin-6 and hepcidin levels in females'. Together they form a unique fingerprint.

Cite this

@article{62894e72f6144d47838095dfee3d342b,

title = "Oral contraception does not alter typical post-exercise interleukin-6 and hepcidin levels in females",

abstract = "{\textcopyright} 2013 Sports Medicine Australia. Objectives: The post-exercise interleukin-6 (IL-6) and hepcidin response was investigated during the hormone-deplete and hormone-replete phases of an estradiol and progestogen regulated oral contraceptive cycle (OCC). Design: Counterbalanced, repeated measures cross-over study. Methods: Ten active female monophasic oral contraceptive pill (OCP) users completed two 40min treadmill running trials at 75% of their pre-determined peak oxygen uptake velocity (vVO2peak). These trials were randomly performed in two specific phases of the OCC: (a) Day 2-4, representing a hormone-free withdrawal period (D-0); (b) Day 12-14, representing the end of the first week of active hormone therapy (D+7). Venous blood samples were drawn pre-, post- and 3h post-exercise. Results: In both trials, serum IL-6 was significantly elevated (p",

author = "Marc Sim and Brian Dawson and Grant Landers and D.W. Swinkels and H. Tjalsma and Bu Yeap and Debbie Trinder and Peter Peeling",

year = "2015",

doi = "10.1016/j.jsams.2013.11.008",

language = "English",

volume = "18",

pages = "8--12",

journal = "Journal of Science and Medicine in Sport",

issn = "1440-2440",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Oral contraception does not alter typical post-exercise interleukin-6 and hepcidin levels in females

AU - Sim, Marc

AU - Dawson, Brian

AU - Landers, Grant

AU - Swinkels, D.W.

AU - Tjalsma, H.

AU - Yeap, Bu

AU - Trinder, Debbie

AU - Peeling, Peter

PY - 2015

Y1 - 2015

N2 - © 2013 Sports Medicine Australia. Objectives: The post-exercise interleukin-6 (IL-6) and hepcidin response was investigated during the hormone-deplete and hormone-replete phases of an estradiol and progestogen regulated oral contraceptive cycle (OCC). Design: Counterbalanced, repeated measures cross-over study. Methods: Ten active female monophasic oral contraceptive pill (OCP) users completed two 40min treadmill running trials at 75% of their pre-determined peak oxygen uptake velocity (vVO2peak). These trials were randomly performed in two specific phases of the OCC: (a) Day 2-4, representing a hormone-free withdrawal period (D-0); (b) Day 12-14, representing the end of the first week of active hormone therapy (D+7). Venous blood samples were drawn pre-, post- and 3h post-exercise. Results: In both trials, serum IL-6 was significantly elevated (p

AB - © 2013 Sports Medicine Australia. Objectives: The post-exercise interleukin-6 (IL-6) and hepcidin response was investigated during the hormone-deplete and hormone-replete phases of an estradiol and progestogen regulated oral contraceptive cycle (OCC). Design: Counterbalanced, repeated measures cross-over study. Methods: Ten active female monophasic oral contraceptive pill (OCP) users completed two 40min treadmill running trials at 75% of their pre-determined peak oxygen uptake velocity (vVO2peak). These trials were randomly performed in two specific phases of the OCC: (a) Day 2-4, representing a hormone-free withdrawal period (D-0); (b) Day 12-14, representing the end of the first week of active hormone therapy (D+7). Venous blood samples were drawn pre-, post- and 3h post-exercise. Results: In both trials, serum IL-6 was significantly elevated (p

U2 - 10.1016/j.jsams.2013.11.008

DO - 10.1016/j.jsams.2013.11.008

M3 - Article

C2 - 24373771

VL - 18

SP - 8

EP - 12

JO - Journal of Science and Medicine in Sport

JF - Journal of Science and Medicine in Sport

SN - 1440-2440

IS - 1

ER -